簡介：
Rhinomed Limited, a nasal medical technology and drug delivery company, engages in the research, development, and commercialization of consumer and medical devices worldwide. The company identifies, acquires, and commercializes late stage therapeutic delivery technologies. Its product portfolio includes Turbine, a nasal dilator designed to assist to breathe easier during aerobic exercise; Mute, a nasal dilator designed to enhance airflow and reduce snoring while sleep; and Pronto, a nasal dilator to open nose and improve airflow. The company sells its products through wholesalers, retail stores, and clinics, as well as online. It serves clinicians and health care organizations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Richmond, Australia.